Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.
Agilent Technologies Analyst Ratings
A Glimpse Into The Expert Outlook On Vertex Pharmaceuticals Through 19 Analysts
Vertex Pharmaceuticals Analyst Ratings
Reported Sunday, Bluebird Bio Highlights 9-Year Data For LYFGENIA Gene Therapy: Sustained Benefits In Sickle Cell Disease Patients At ASH 2024
Executive Reshuffles: INTC, ZS, ETSY and SEDG
Bluebird Bio Announced Long-Term Follow-Up Data Continue To Support Beti-Cel As Potentially Curative Gene Therapy For Β-Thalassemia Patients Who Require Regular Transfusions Through Achievement Of Durable Transfusion Independence And Normal Or...
Weekly Buzz: Now THOSE are records!!
Lilly Tops Morgan Stanley's Biopharma Pick List for 2025
Index Records are BACK for Friday Market While Unemployment Climbs | Live Stock
Beam Therapeutics Picks Ironwood Pharmaceuticals Finance and Operations Chief as CFO
Thursday Indexes Pull back From Records While Bitcoin Sets New Ones | Wall Street Today
12 Health Care Stocks Moving In Thursday's Pre-Market Session
100k Bitcoin! Market Pulls Back After Records | Live Stock
FDA-Approved Sickle Cell Therapies From Bluebird Bio And Vertex Join Medicaid Innovation Program
Bluebird Bio Shares Are Trading Higher After the Company Announced It Joined the CMMI Cell and Gene Therapy Access Model and Will Offer Outcomes-based Agreements to Expand Medicaid Access to LYFGENIA Gene Therapy for Sickle Cell Disease.
CMS Rolls Out New Payment Model for Vertex, Bluebird Gene Therapies
10 Health Care Stocks Whale Activity In Today's Session
S&P and Nasdaq on Track for Third Record Close This Week | Live Stock
Ready Capital Corporation Announces Pricing of Public Offering of Senior Notes Due 2029
Fresh Closing Highs from S&P 500 and Nasdaq | Wall Street Today